I just wonder how the clinical trials worked for a drug that is used for such a purpose….
Novartis and its Sandoz unit, maker of a generic version of an anesthetic used in lethal injections in the United States, have taken steps to try to stop the drug ending up in the United States. Click here to read the Reuters article.
Or as Pfizer’s Craig Lipset asked on Linkedin:
Time to invest in firing squads?